US Stock MarketDetailed Quotes

TYPTF TRYPTAMINE THERAPEUTICS LIMITED

Watchlist
  • 0.009
  • -0.021-70.00%
15min DelayClose Nov 13 16:00 ET
  • 0.009
  • 0.0000.00%
Post 18:12 ET
11.49MMarket Cap-375P/E (TTM)

TRYPTAMINE THERAPEUTICS LIMITED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
77.60%-276.64K
31.34%-1.24M
-89.44%-1.8M
-10.59%-949.59K
-858.65K
Net PPE purchase and sale
75.41%-276.64K
30.77%-1.13M
-157.26%-1.63M
-18.39%-631.8K
---533.65K
Net intangibles purchase and sale
----
----
----
----
---325K
Net investment purchase and sale
----
----
32.12%-188.57K
---277.79K
----
Net other investing changes
----
-832.99%-109.95K
137.50%15K
---40K
----
Cash from discontinued investing activities
Investing cash flow
77.60%-276.64K
31.34%-1.24M
-89.44%-1.8M
-10.59%-949.59K
---858.65K
Financing cash flow
Cash flow from continuing financing activities
-51.24%918.56K
-90.86%1.88M
314.61%20.61M
-32.92%4.97M
7.41M
Net issuance payments of debt
-112.37%-337.56K
4,817.09%2.73M
---57.86K
----
----
Net common stock issuance
--1.57M
----
308.75%21.16M
-30.14%5.18M
--7.41M
Net other financing activities
84.06%-124.34K
-57.56%-779.85K
-167.76%-494.94K
---184.85K
----
Cash from discontinued financing activities
Financing cash flow
-51.24%918.56K
-90.86%1.88M
314.61%20.61M
-32.92%4.97M
--7.41M
Net cash flow
Beginning cash position
-61.91%4.85M
630.02%12.72M
-60.56%1.74M
8,332.96%4.42M
--52.4K
Current changes in cash
59.33%-3.2M
-171.76%-7.88M
510.30%10.98M
-161.28%-2.68M
--4.37M
Effect of exchange rate changes
-95.37%78
66.34%1.69K
--1.01K
----
----
End cash Position
-66.11%1.64M
-61.91%4.85M
630.02%12.72M
-60.56%1.74M
--4.42M
Free cash flow
57.21%-4.13M
-2.10%-9.65M
-29.00%-9.45M
-140.82%-7.33M
---3.04M
Currency Unit
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities 77.60%-276.64K31.34%-1.24M-89.44%-1.8M-10.59%-949.59K-858.65K
Net PPE purchase and sale 75.41%-276.64K30.77%-1.13M-157.26%-1.63M-18.39%-631.8K---533.65K
Net intangibles purchase and sale -------------------325K
Net investment purchase and sale --------32.12%-188.57K---277.79K----
Net other investing changes -----832.99%-109.95K137.50%15K---40K----
Cash from discontinued investing activities
Investing cash flow 77.60%-276.64K31.34%-1.24M-89.44%-1.8M-10.59%-949.59K---858.65K
Financing cash flow
Cash flow from continuing financing activities -51.24%918.56K-90.86%1.88M314.61%20.61M-32.92%4.97M7.41M
Net issuance payments of debt -112.37%-337.56K4,817.09%2.73M---57.86K--------
Net common stock issuance --1.57M----308.75%21.16M-30.14%5.18M--7.41M
Net other financing activities 84.06%-124.34K-57.56%-779.85K-167.76%-494.94K---184.85K----
Cash from discontinued financing activities
Financing cash flow -51.24%918.56K-90.86%1.88M314.61%20.61M-32.92%4.97M--7.41M
Net cash flow
Beginning cash position -61.91%4.85M630.02%12.72M-60.56%1.74M8,332.96%4.42M--52.4K
Current changes in cash 59.33%-3.2M-171.76%-7.88M510.30%10.98M-161.28%-2.68M--4.37M
Effect of exchange rate changes -95.37%7866.34%1.69K--1.01K--------
End cash Position -66.11%1.64M-61.91%4.85M630.02%12.72M-60.56%1.74M--4.42M
Free cash flow 57.21%-4.13M-2.10%-9.65M-29.00%-9.45M-140.82%-7.33M---3.04M
Currency Unit AUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data